Hematology, immunology, and infectious disease : neonatology questions and controversies Robin K Ohls and Akhil Maheshwari

By:

OHLS Robin K [author - MD, Professor of Pediatrics - University of New Mexico, Associate Director, Pediatrics - Clinical Translational Science Center, University of New Mexico Health Sciences, Albuquerque, New Mexico]

Contributor(s):

Maheshwari, Akhil [Author - MD, Associate Professor of Pediatrics and Pharmacology, Chief, Division of Neonatology, Director, Neonatology Fellowship Program, Director, Center for Neonatology and Pediatric Gastrointestinal Disease - University of Illinois at Chicago, Medical Director - Neonatology Intensive Care Unit and Immediate Care Nursery, Children's Hospital of University of Illinois, Chicago, Illinois]
Polin Richard A [consulting editor - MD, Professor of Pediatrics, College of Physicians and Surgeons, Columbia University, Vice Chairman for Clinical and Academic Affairs, Department of Pediatrics, Director, Division of Neonatology, Morgan Stanley Children's Hospital of New York- Presbyterian, Columbia University Medical Center, New York]

Material type: Text

TextLanguage: English Series: Neonatology questions and controversies seriesPublication details: Philadelphia Elsevier Saunders, 2012.Edition: SecondDescription: 345 pages 27 cmISBN:

9781437726626 (hbk)

Subject(s):

LOC classification:

RJ269.5 OHL

Contents:

Front Cover; IFC; Neonatology Questions and Controversies; Neonatology Questions and Controversies; Neonatology Questions and Controversies; Copyright; Contributors; Series Foreword; Preface; Contents; 1 -- Stem Cell Therapy in Neonates-the Time Has (Almost) Come; Stem cells: important in development and disease; Mesenchymal stromal cells: orchestrator of immune response and healing processes; Endothelial colony-forming cells: when angiogenesis counts; Amnion epithelial cells-don't discount the placenta; Bronchopulmonary dysplasia and stem cell therapy Prophylactic mesenchymal stromal cell therapyRescue mesenchymal stromal cell therapy; It's in the juice-MSCs act via a paracrine effect; Other stem cells for bronchopulmonary dysplasia; Endothelial progenitor cells and endothelial colony-forming cells; Human amnion epithelial cells; Summary; Mesenchymal stromal cell therapy for neurologic diseases of newborn; Intraventricular hemorrhage; Hypoxic-ischemic encephalopathy; Neonatal stroke; Mesenchymal stromal cells for congenital heart disease; Mechanisms of action of stem cells in neonatal diseases; Stem cells targeting the immune response Stem cells and growth factorsExtracellular vesicles: exosomes and microvesicles; Summary; Clinical stem cell trials; Completed stem cell trials for neonatal diseases; Lessons from nonneonatal stem cell trials; Going forward-has the time come?; Conclusion; REFERENCES; 2 -- Genome and Exome Sequencing: Can It Impact Clinical Care in the Neonatal Intensive Care Unit?; Next-generation sequencing; Genome vs. exome vs. targeted-panel sequencing; Clinical utility of next-generation sequencing in neonatal intensive care unit; Newborn screening; Future perspectives; REFERENCES 3 -- Transfusion Thresholds in the Neonatal Intensive Care Unit: What Have Recent Randomized Controlled Trials Taught Us?Transfusion risks; When to transfuse; Acute anemia; Chronic anemia; Preoperative target for infants undergoing surgery; Studies evaluating target hemoglobin or hematocrit; Erythropoiesis-stimulating agents and transfusions; Search for other transfusion markers; Selection of red cell products; Red cell transfusion volumes; When families oppose transfusions; Summary and recommendations; REFERENCES; 4 -- Donor Milk Compared with Mother's Own Milk; Secretory immunoglobulin A LactoferrinLysozyme; Epidermal growth factor; Lipase; Oligosaccharides; Transforming growth factor; Cytokines and chemokines; Cells; Erythropoietin; Summary; REFERENCES; 5 -- Will Standardized Approaches to Nutrition Decrease Necrotizing Enterocolitis?; General approach to enteral feeding to prevent necrotizing enterocolitis in preterm infants; Enteral feeding during treatment for patent ductus arteriosus; Enteral feedings and red blood cell transfusions; Quality improvement framework; Conclusion; REFERENCES; 6 -- Nonimmune Neonatal Hemolytic Anemia: Recent Advances in Diagnosis and Treatment

Reviews from LibraryThing.com:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	Copy number	Status	Barcode
Book	Medical School Open Shelf	RJ269.5 OHL (Browse shelf(Opens below))	147334	Available	BK133782
Book	Medical School Open Shelf	RJ269.5 OHL (Browse shelf(Opens below))	147333	Available	BK133906
Book	Medical School Open Shelf	RJ269.5 OHL (Browse shelf(Opens below))	147332	Available	BK133894
Book	Medical School Open Shelf	RJ269.5 OHL (Browse shelf(Opens below))	147331	Available	BK133407
Book	Medical School Open Shelf	RJ269.5 OHL (Browse shelf(Opens below))	147232	Available	BK133770

Includes bibliographical references and index.

Front Cover; IFC; Neonatology Questions and Controversies; Neonatology Questions and Controversies; Neonatology Questions and Controversies; Copyright; Contributors; Series Foreword; Preface; Contents; 1 --
Stem Cell Therapy in Neonates-the Time Has (Almost) Come; Stem cells: important in development and disease; Mesenchymal stromal cells: orchestrator of immune response and healing processes; Endothelial colony-forming cells: when angiogenesis counts; Amnion epithelial cells-don't discount the placenta; Bronchopulmonary dysplasia and stem cell therapy Prophylactic mesenchymal stromal cell therapyRescue mesenchymal stromal cell therapy; It's in the juice-MSCs act via a paracrine effect; Other stem cells for bronchopulmonary dysplasia; Endothelial progenitor cells and endothelial colony-forming cells; Human amnion epithelial cells; Summary; Mesenchymal stromal cell therapy for neurologic diseases of newborn; Intraventricular hemorrhage; Hypoxic-ischemic encephalopathy; Neonatal stroke; Mesenchymal stromal cells for congenital heart disease; Mechanisms of action of stem cells in neonatal diseases; Stem cells targeting the immune response Stem cells and growth factorsExtracellular vesicles: exosomes and microvesicles; Summary; Clinical stem cell trials; Completed stem cell trials for neonatal diseases; Lessons from nonneonatal stem cell trials; Going forward-has the time come?; Conclusion; REFERENCES; 2 --
Genome and Exome Sequencing: Can It Impact Clinical Care in the Neonatal Intensive Care Unit?; Next-generation sequencing; Genome vs. exome vs. targeted-panel sequencing; Clinical utility of next-generation sequencing in neonatal intensive care unit; Newborn screening; Future perspectives; REFERENCES 3 --
Transfusion Thresholds in the Neonatal Intensive Care Unit: What Have Recent Randomized Controlled Trials Taught Us?Transfusion risks; When to transfuse; Acute anemia; Chronic anemia; Preoperative target for infants undergoing surgery; Studies evaluating target hemoglobin or hematocrit; Erythropoiesis-stimulating agents and transfusions; Search for other transfusion markers; Selection of red cell products; Red cell transfusion volumes; When families oppose transfusions; Summary and recommendations; REFERENCES; 4 --
Donor Milk Compared with Mother's Own Milk; Secretory immunoglobulin A LactoferrinLysozyme; Epidermal growth factor; Lipase; Oligosaccharides; Transforming growth factor; Cytokines and chemokines; Cells; Erythropoietin; Summary; REFERENCES; 5 --
Will Standardized Approaches to Nutrition Decrease Necrotizing Enterocolitis?; General approach to enteral feeding to prevent necrotizing enterocolitis in preterm infants; Enteral feeding during treatment for patent ductus arteriosus; Enteral feedings and red blood cell transfusions; Quality improvement framework; Conclusion; REFERENCES; 6 --
Nonimmune Neonatal Hemolytic Anemia: Recent Advances in Diagnosis and Treatment

There are no comments on this title.

to post a comment.

here